11-112087868-C-T
Variant summary
Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PVS1PS3PM2PP5_Very_Strong
The NM_003002.4(SDHD):c.64C>T(p.Arg22*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000581232: A study including somatic and germline DNA analyses, cosegregation analyses, enzyme function studies and gene expression studies concluded that this mutation is associated with a complete loss of mitochondrial complex II activity and a high expression of angiogenic factors (Gimenez-Roqueplo AP et al. Am. J. Hum. Genet. 2001 Dec" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. R22R) has been classified as Likely benign.
Frequency
Consequence
NM_003002.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Carney-Stratakis syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- mitochondrial complex II deficiency, nuclear type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 3Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- mitochondrial complex II deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intestinal cancerInheritance: AD Classification: LIMITED Submitted by: G2P
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 22 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003002.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SDHD | MANE Select | c.64C>T | p.Arg22* | stop_gained | Exon 2 of 4 | NP_002993.1 | O14521-1 | ||
| SDHD | c.64C>T | p.Arg22* | stop_gained | Exon 2 of 5 | NP_001263435.1 | O14521-4 | |||
| SDHD | c.64C>T | p.Arg22* | stop_gained | Exon 2 of 3 | NP_001263432.1 | A0A0S2Z4H7 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SDHD | TSL:1 MANE Select | c.64C>T | p.Arg22* | stop_gained | Exon 2 of 4 | ENSP00000364699.3 | O14521-1 | ||
| SDHD | TSL:1 | c.64C>T | p.Arg22* | stop_gained | Exon 2 of 3 | ENSP00000436217.1 | O14521-3 | ||
| ENSG00000255292 | TSL:3 | n.64C>T | non_coding_transcript_exon | Exon 2 of 6 | ENSP00000456434.1 | H3BRW5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459576Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 726282 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at